Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Longitudinal tau and meta… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease

Artikel i vetenskaplig tidskrift
Författare A. Leuzy
Claudia Cicognola
K. Chiotis
L. Saint-Aubert
L. Lemoine
N. Andreasen
Henrik Zetterberg
K. Q. Ye
Kaj Blennow
Kina Höglund
A. Nordberg
Publicerad i European Journal of Nuclear Medicine and Molecular Imaging
Volym 46
Nummer/häfte 5
Sidor 1152-1163
ISSN 1619-7070
Publiceringsår 2019
Publicerad vid Institutionen för neurovetenskap och fysiologi
Institutionen för neurovetenskap och fysiologi, sektionen för psykiatri och neurokemi
Sidor 1152-1163
Språk en
Länkar dx.doi.org/10.1007/s00259-018-4242-...
Ämnesord Alzheimer's disease, Tau, CSF, PET imaging, [F-18]FDG, [F-18]THK5317, positron-emission-tomography, fluid amyloid-beta, cerebrospinal-fluid, glucose-metabolism, neurofibrillary pathology, phospho-tau, human brain, biomarkers, association, deposition, Radiology, Nuclear Medicine & Medical Imaging
Ämneskategorier Radiologi

Sammanfattning

Purpose Studies comparing CSF and PET tau biomarkers have included only commercial CSF assays examining specific phosphorylation sites (e.g. threonine 181, P-tau(181p)) and mid-domain tau (i.e. total tau, T-tau). Moreover, these studies did not examine CSF tau levels in relation to cerebral glucose metabolism. We thus aimed to examine CSF tau measures, using both commercial and novel assays, in relation to [F-18]THK5317 (tau) and [F-18]FDG PET (glucose metabolism). Methods Fourteen Alzheimer's disease (AD) patients (seven prodromal, seven dementia) underwent [F-18]THK5317 and [F-18]FDG PET studies, with follow-up performed in ten subjects (six prodromal, four dementia) after 17 months. In addition to commercial assays, novel measures capturing N-terminus+mid-domain (tau N-Mid) and C-terminally truncated (tau-368) fragments were included. Results While the levels of all forms of CSF tau were found to be inversely associated with baseline [F-18]FDG uptake, associations with baseline [F-18]THK5317 uptake varied in relation to the degree of isocortical hypometabolism ([F-18]FDG SUVR). Changes in the levels of the novel CSF markers tracked longitudinal changes in tracer uptake better than changes in P-tau(181p) and T-tau levels, and improved concordance with dichotomized regional [F-18]THK5317 measures. Conclusion Our findings suggest that neurodegeneration may modulate the relationship between CSF and PET tau biomarkers, and that, by comparison to P-tau(181p) and T-tau, tau-368 and tau N-Mid may better capturetau pathology and synaptic impairment.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?